The tepid reception to Venture Global's ambitious valuation target shows companies need to set realistic expectations when ...

Market participants widely expect 2025 to be a boom year for IPOs as President-elect Donald Trump eases regulation while the ...

In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Investors, analysts, and founders could probably use a dose of optimism ... The Nasdaq had a banner year, with 171 IPOs raising $22.7 billion. And not all IPOs have been busts, post launch.

The biotech has applied to list on the Nasdaq under the ticker “MTSR.” Metsera plans to use the IPO to fund a phase 3 trial of MET-097i—a subcutaneous GLP-1 receptor agonist that is the ...